subject: Welichem Biotech Inc. (wbi) - Financial And Strategic Swot Analysis Review [print this page] Welichem Biotech IncWelichem Biotech Inc. (Welichem, formerly known as Welichem Technology Corporation) is a public share holding company. It is principally engaged in the discovery, research and development of therapeutics to treat autoimmune/inflammatory diseases and cancers. The company investigates its drug candidates using its Symbiochem technology platform. The product pipeline of the company consists of two drug candidates namely WBI-1001 and WBI-2100. Its leading drug candidate, WBI-1001 is an anti-inflammatory drug targeting mild to moderate forms of plaque psoriasis. WBI-2100 is an anti-cancer/neutrophil boosting drug candidate targeting solid tumors. Recently, the company initiated a 12-Week, double-blinded, placebo-controlled Phase II trial of WBI-1001 Cream. Welichem is headquartered in Burnaby, Canada. ( http://www.companyprofilesandconferences.com/report/Welichem-Biotech-Inc-WBI-Financial-and-Strategic-SWOT-Analysis-Review.html )
This comprehensive SWOT profile of Welichem Biotech Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Welichem Biotech Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
For more information kindly visit : http://www.companyprofilesandconferences.com/report/Welichem-Biotech-Inc-WBI-Financial-and-Strategic-SWOT-Analysis-Review.html
